Endovia Health Sciences, Inc. (EDVA)
NYSEAMERICAN: EDVA · Real-Time Price · USD
0.2413
-0.0048 (-1.95%)
At close: Sep 21, 2026, 4:00 PM EDT
0.2442
+0.0029 (1.20%)
After-hours: Sep 21, 2026, 6:45 PM EDT
Endovia Health Sciences Employees
As of December 31, 2025, Endovia Health Sciences had 2 total employees, including 1 full-time and 1 part-time employees. The number of employees decreased by 19 or -90.48% compared to the previous year.
Employees
2
Change (1Y)
-19
Growth (1Y)
-90.48%
Revenue / Employee
$16,045
Profits / Employee
-$9,417,950
Market Cap
1.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | -19 | -90.48% | 1 | 1 |
| Dec 31, 2024 | 21 | -11 | -34.38% | 21 | 0 |
| Dec 31, 2023 | 32 | -8 | -20.00% | 32 | 0 |
| Dec 31, 2022 | 40 | 19 | 90.48% | 40 | 0 |
| Dec 31, 2021 | 21 | - | - | 21 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Virax Biolabs Group | 26 |
| Curis | 24 |
| Tessera Defense and Homeland Security | 20 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
| CDT Equity | 4 |
| Oragenics | 3 |
EDVA News
- 3 days ago - Endovia Health Sciences Proxy statement: Proxy filing - Filings
- 21 days ago - Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline - GlobeNewsWire
- 27 days ago - Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program - GlobeNewsWire
- 4 weeks ago - Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday - GlobeNewsWire
- 4 weeks ago - Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic Transformation Toward Endovia Health Sciences - GlobeNewsWire
- 5 weeks ago - Splash Beverage Group to Rebrand as Endovia Health Sciences - GlobeNewsWire
- 6 weeks ago - Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway - GlobeNewsWire
- 7 weeks ago - Splash Beverage Group Expands CannEpil® Platform into Veterinary Therapeutics, Establishing Second FDA-Regulated Pharmaceutical Development Program - GlobeNewsWire